Published in

American Society for Pharmacology and Experimental Therapeutics (ASPET), The Journal of Pharmacology and Experimental Therapeutics, 2(377), p. 293-304, 2021

DOI: 10.1124/jpet.120.000238

Links

Tools

Export citation

Search in Google Scholar

SAR340835, a novel selective NCX inhibitor, improves cardiac function and restores sympathovagal balance in Heart Failure.

Journal article published in 2021 by Michel Pelat, Fabrice Barbe, Cyril Daveu, Laetitia Ly-Nguyen, Thomas Lartigue, Suzanne Marque, Georges Tavares, Veronique Ballet, Jean-Michel Guillon, Klaus Steinmeyer, Klaus Wirth, Heinz Gögelein, Petra Arndt, Nils Rackelmann, John Weston and other authors.
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO